Treatment of Community-Acquired Pneumonia: A Focus on Lefamulin

被引：0
|
作者：
Nathaniel Eraikhuemen
Daniel Julien
Alandra Kelly
Taylor Lindsay
Dovena Lazaridis
机构：
[1] Florida A&M University College of Pharmacy and Pharmaceutical Sciences,Department of Pharmacy
[2] Institute of Public Health,undefined
[3] Memorial Regional Hospital South,undefined
[4] Memorial Regional Hospital,undefined
来源：
Infectious Diseases and Therapy | 2021年 / 10卷
关键词：
BC-3781; Community-Acquired pneumonia; Clinical pharmacology; Lemafulin; Mechanism of action;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Lefamulin is the first pleuromutilin antibiotic approved for the treatment of bacterial infections in humans. Pleuromutilin antibiotics exert their unique mechanism of action which makes them less susceptible to the development of bacterial resistance and low probability of cross-resistance to the other antimicrobial classes.
引用
收藏
页码：149 / 163
页数：14
相关论文
共 50 条
  • [1] Treatment of Community-Acquired Pneumonia: A Focus on Lefamulin
    Eraikhuemen, Nathaniel
    Julien, Daniel
    Kelly, Alandra
    Lindsay, Taylor
    Lazaridis, Dovena
    INFECTIOUS DISEASES AND THERAPY, 2021, 10 (01) : 149 - 163
  • [2] Therapeutic potential of lefamulin in the treatment of community-acquired pneumonia
    Perry, Whitney
    Golan, Yoav
    FUTURE MICROBIOLOGY, 2019, 14 (11) : 927 - 939
  • [3] Lefamulin (Xenleta) for Community-Acquired Bacterial Pneumonia
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2019, 61 (1581): : 145 - 148
  • [4] Leave it to Lefamulin: A Pleuromutilin Treatment Option in Community-Acquired Bacterial Pneumonia
    Lee, Young Ran
    Jacobs, Katy Louise
    DRUGS, 2019, 79 (17) : 1867 - 1876
  • [5] Leave it to Lefamulin: A Pleuromutilin Treatment Option in Community-Acquired Bacterial Pneumonia
    Young Ran Lee
    Katy Louise Jacobs
    Drugs, 2019, 79 : 1867 - 1876
  • [6] Lefamulin vs moxifloxacin for community-acquired bacterial pneumonia
    Tang, Hung-Jen
    Wang, Jui-Hsiang
    Lai, Chih-Cheng
    MEDICINE, 2020, 99 (29) : E21223
  • [7] Lefamulin-A New Antibiotic for Community-Acquired Pneumonia
    Malani, Preeti N.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 322 (17): : 1671 - 1672
  • [8] Lefamulin: A Novel Oral and Intravenous Pleuromutilin for the Treatment of Community-Acquired Bacterial Pneumonia
    George G. Zhanel
    Christina Deng
    Sheryl Zelenitsky
    Courtney K. Lawrence
    Heather J. Adam
    Alyssa Golden
    Liam Berry
    Frank Schweizer
    Michael A. Zhanel
    Neal Irfan
    Denice Bay
    Philippe Lagacé-Wiens
    Andrew Walkty
    Lionel Mandell
    Joseph P. Lynch
    James A. Karlowsky
    Drugs, 2021, 81 : 233 - 256
  • [9] Lefamulin: A Novel Oral and Intravenous Pleuromutilin for the Treatment of Community-Acquired Bacterial Pneumonia
    Zhanel, George G.
    Deng, Christina
    Zelenitsky, Sheryl
    Lawrence, Courtney K.
    Adam, Heather J.
    Golden, Alyssa
    Berry, Liam
    Schweizer, Frank
    Zhanel, Michael A.
    Irfan, Neal
    Bay, Denice
    Lagace-Wiens, Philippe
    Walkty, Andrew
    Mandell, Lionel
    Lynch, Joseph P., III
    Karlowsky, James A.
    DRUGS, 2021, 81 (02) : 233 - 256
  • [10] The clinical efficacy of lefamulin in the treatment of elderly patients with community-acquired bacterial pneumonia
    Tang, Hung-Jen
    Lai, Chih-Cheng
    Chao, Chien-Ming
    JOURNAL OF THORACIC DISEASE, 2020, 12 (08) : 4588 - 4590
12345